Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25
Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25
Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Decline in Short Interest
BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update
Bioxytran Conference: CEO touts broad-spectrum antiviral strategy, cites strong COVID Phase II results
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
Bioxytran (OTCMKTS:BIXT) vs. Structure Therapeutics (NASDAQ:GPCR) Head-To-Head Survey
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
Bioxytran Announces Initiation of Coverage of its Stock by Independent Research
Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
Bioxytran's Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin
Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes
Bioxytran's Antiviral Breakthrough Featured in University of Georgia's $100M HPAI Poultry Innovation Grand Challenge Submission
Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions
Bioxytran's Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs
Bioxytran's Medical Breakthrough in Fighting All Viruses
Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier
Bioxytran's Advisor Releases Book on Hyperbaric Oxygenation Related to Stroke & Alzheimer's Patients
Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist
Bioxytran's Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19
Bioxytran Gets Broad Patent Coverage on 60+ Viruses
Bioxytran Interview at the Emerging Growth Conference
Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials
Bioxytran Initiates a Registrational Trial of Oral ProLectin-M for Mild to Moderate COVID-19 Patients
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board
Bioxytran's positive Phase 2 trial results featured in ‘Vaccines' peer-reviewed journal